As bstract. We have examined the amino acid transport in B cell chronic lymphocytic leukemia and compared it with the amino acid transport in isolated B lymphocytes from human blood and tonsils. L-system transport was measured with 2-amino-2-carboxy-bicyclo (2,2,1)-heptane, which is a synthetic amino acid whose transport is limited to the L-system. Amino acid uptake was subjected to a multicomponent analysis that partitioned the total uptake into the saturable carrier-mediated transport system and the uptake by diffusion. The maximal velocity ofL-system transport in chronic lymphocytic leukemia cells, 81 ,umol/l cell water per min, was <10% that of blood B lymphocytes, which was 1,029 Amol/l cell water per min. The uptake of 2-amino-2-carboxybicyclo (2,2,1)-heptane by tonsillar B cells, by a B lymphocyte cell line, and by blood T-lymphocytes was also 10-fold greater than that observed in chronic lymphocytic leukemic cells. Similarly, the L-system uptake of leucine and phenylalanine, which are naturally occurring amino acids usually transported primarily by the L-system, was reduced in chronic lymphocytic leukemic B cells to 15 and 10% of normal B cells, respectively. Total leucine uptake by chronic lymphocytic leukemic cells, however, was sustained at 30% of that expected because oftransport via an alternative transport system. The A-or ASC-systems, the other major amino acid transport pathways, were not defective in chronic lymphocytic leukemic cells. These data indicate that there is a specific, profound deAddress correspondence to Dr. Segel at the University of Rochester Medical Center, Rochester, NY 14642.
Introduction
The membrane of B lymphocytes in chronic lymphocytic leukemia (CLL)' has at least two distinct biochemical differences from normal B lymphocytes: altered cell surface glycoproteins (1, 2) and a profound decrease in 5'-nucleotidase activity (3) .
A third abnormality that has been described recently is the lack of a 185,000-D cold insoluble globulin in CLL lymphocyte membranes, which is present in the membranes of normal B lymphocytes (4) . It is not known whether the absence of this protein is the cause either of the decrease in membrane sialoproteins or the absence of 5'-nucleotidase activity. We have recently found that the plasma membranes of CLL B lymphocytes have a marked diminution of the L-system of amino acid transport when compared with blood T lymphocytes or with tonsillar lymphocytes (5) .
By using lymphocytapheresis and differential cell separation techniques, we have been able to acquire sufficient numbers of human blood B lymphocytes for amino acid transport studies, and in this report we have been able to compare CLL B lymphocytes with normal human B lymphocytes. Further, we have applied a multicomponent computerized analysis to the calculation of amino acid transport so as to describe quantitatively the carrier mediated and diffusional components of the L-system of transport in lymphocytes. These studies indicate that the Lsystem for amino acid transport is markedly diminished in CLL cells when compared either with blood B lymphocytes, tonsillar B lymphocytes, or with B lymphocyte lines derived from healthy donors.
Methods
Preparation of lymphocytes. Human blood T and B lymphocytes were prepared from the plateletpheresis residues of healthy blood donors (6) . 1 lymphocytes were separated from the mixed cell populations using a nylon wool adherence technique (7) . 24 g of nylon wool were packed in a 7 X 6-cm polypropylene column. The nylon wool was compacted to a volume of 240 ml with a coarse (16 squares/in.) nylon mesh disc that fit snugly against the inside of the column. The column was heat sterilized and washed with 1,000 ml of tissue culture medium containing 5% bovine calf serum at 370C. 8 ml of a cell suspension that contained 3 X 108 lymphocytes/ml was applied to the column and washed into the nylon wool with an additional 40 ml of TC-199 with 10% bovine calf serum. The column was sealed and incubated at 370C
for 45 min to allow adherence of the B lymphocytes. The nonadherent T lymphocytes were eluted from the column with 100 ml TC-199 with 10% bovine calf serum. The column was washed with an additional 1,000 ml ofbuffer. The adherent B lymphocytes were eluted by dispersing the nylon wool in 200 ml of buffer and by decanting the suspended cells. This procedure resulted in the preparation of 1-2 X 108 B lymphocytes for amino acid transport studies. Tonsillar lymphocytes were prepared by disruption of fresh tonsils and by step gradient separation of the cell suspension, as previously described (8) . CLL B cells were obtained from the blood of patients with chronic leukemia who had stable disease and who had not received chemotherapy in the previous 6 mo. T lymphocytes were quantified by measurement of the proportion of E-rosette-forming cells, and B lymphocytes were identified by the presence of immunoglobulin on their surface using fluorescein-conjugated anti-Ig. The B lymphocyte line, RPMI 1788, derived from normal blood lymphocytes, is maintained in long-term culture in our laboratory. The cells were grown in McCoy's 5A medium with 10% fetal calf serum and were subcultured twice a week. The cells were removed from long-term culture and washed twice in Hank's buffered salt solution before resuspension and study.
Pathwaysfor amino acid uptake. Mammalian cells have three major pathways for amino acid transport, the L-, A-, and ASC-systems (9) (10) (11) (12) . The L-system transports amino acids with rings or branches in their side chains such as leucine and phenylalanine, is transstimulated by intracellular L-system amino acids, and is insensitive to the sodium gradient across the plasma membrane. The synthetic amino acid, 2-amino-2-carboxy-bicyclo (2,2, )-heptane (BCH) is transported selectively by the L-system and is used to characterize this pathway (I 1). The A apd ASC transport systems are dependent on the transmembrane sodium gradient. The A-system transports neutral amino acids with short, polar, or linear side chains, exhibits transinhibition, transports N-methylated amino acids, and can be characterized by the synthetic amino acid, methyl-amino-isobutyric acid (methyl-AIB), which is transported selectively by the A-system. The ASC-system transports alanine, serine, and cysteine, exhibits transstimulation, and does not transport N-methylated amino acids. There is no synthetic or natural occurring amino acid which is transported by the ASC-system alone.
Measurement ofamino acid uptake. The initial velocity (pi) ofamino acid uptake was measured in Hank's buffered salt solution, pH 7.45, which contained I g/dl human albumin as previously described (9) . In brief, the Pi was measured after 30 min of preincubation at 370C to allow depletion of the internal amino acid pool. Uptake was initiated by adding 0.5 MCi/ml of'4C-labeled amino acid with sufficient unlabeled carrier to provide amino acid concentrations from 0.1 to 4 mM. The samples were separated from the incubation media using abutylphthalate, corn oil gradient, and the Pi was calculated from measurements of uptake made at 0.5 min for leucine and BCH and at I min for methyl-AIB.
No uptake of amino acids was observed at 4VC. The Pi of amino acid transport was calculated from the formula: Pi COOL is the micromolar concentration of amino acid in incubation medium. Pi is expressed as micromoles per liter cell water per minute.
Calculation ofthe kinetics ofamino acid uptake. A multicomponent analysis was used to analyze the kinetic parameters ofamino acid uptake (10) . The multicomponent analysis separates the rate of appearance of amino acid in lymphocytes into a saturable, carrier-mediated process that fits a Michaelis-Menten kinetic analysis and a passive diffusion process whose rate depends upon the diffusion constant and the difference in amino acid concentration across the plasma membrane. A computer program was used to calculate the best values for the K., P., and diffusion constant so as to minimize the sum of the squares of the
-Cingdie(n))Jj where S is the sum of the squared residuals; v(n) is the measured velocity corresponding to C,,, 4(n); and C(,,(n) and Ci, , 4n) are the values for the nt external and internal amino acid concentrations, respectively. The derivation of this analysis has been published previously (10 In order to define the contribution of the T lymphocytes to the residual BCH uptake, we studied five additional CLL populations before and after removal of T cells. In Fig. 2 , the vi of BCH uptake at BCH concentrations from 0.125 to 1 mM is shown for unseparated and T cell-depleted CLL lymphocytes. In these studies, the proportion of T lymphocytes was reduced from 5 to 0.5%. There was no significant difference between the unseparated and T-depleted cells (Fig. 2) .
In of BCH uptake in a CLL cell population before and after the removal of 5% T lymphocytes, the P.. of BCH transport was measured in three mixtures of CLL and normal blood lymphocytes (Table IV) . In this study, we again observed a 10-fold higher Im. for BCH uptake in normal blood lymphocytes as compared with CLL lymphocytes. Using these values, predicted uptakes for three mixtures were calculated. The observed uptakes were very similar to the predicted uptakes, and a mixture of 5% normal blood lymphocytes and 95% CLL lymphocytes was different from 100% CLL lymphocytes. This confirmed that the sensitivity of our uptake studies could detect a 5% decrement in T cells from a CLL population.
Leucine transport by CLL cells and other lymphocyte types. Leucine is an amino acid that is transported by the L-system in most cell types (12) . The Pi for leucine in CLL lymphocytes, 193 Mmol/l cell water per min, is less than one-halfthat ofblood B lymphocytes, blood T lymphocytes, and tonsillar lymphocytes ( Table V) . The initial studies of leucine uptake were performed at a concentration of 0.1 mM. The diminished transport rate for leucine at this relatively low amino acid concentration was reflected also in the Vms, of leucine uptake. The Pm., 450 Mmol/l cell water per min, was approximately one-third that observed in blood B, blood T or tonsillar lymphocytes (Table   V) . The Km for leucine in CLL cells, 208 ,M, was slightly higher than that observed in tonsillar or blood T lymphocytes, but was lower than that measured in blood B lymphocytes (459 uM). The higher Km for leucine in blood B cells was in keeping with the higher Km for BCH, which indicates a lower carrier affinity for amino acids transported by the L-system in blood B cells. BCH transport in CLL B cells, however, indicated that leucine uptake should be -10% of normal B cells, whereas uptake was -35% of normal B cells. This finding suggested that leucine may be transported by an alternative uptake pathway (see below).
Competitive inhibition ofleucine transport by unlabeled BCH. ['4C]leucine uptake was measured in the presence of 5 mM BCH in order to define the proportion ofleucine uptake mediated by the L-system. BCH blocked 70% of leucine uptake in blood T lymphocytes, 55% in blood B lymphocytes, but blocked only 30% of leucine uptake in CLL lymphocytes (Table VI) . BCH blocked its own uptake by >80% in the three lymphocyte types. These data indicated a marked decrease in leucine transport via the L-system in CLL lymphocytes. Since this finding implied that leucine is transported in CLL cells to a significant degree by a system other than the L-system, we examined the role of the ASC-and A-systems in leucine uptake.
Sodium dependence ofleucine transport. Sodium-dependent leucine transport was calculated as the difference in the rate of leucine uptake at a sodium concentration of 140 mM and at a sodium concentration of 10 mM. Since the internal concentration of sodium in human blood lymphocytes is -15 mM (13), an external sodium concentration of 10 mM eliminates the sodium gradient across the lymphocyte plasma membrane. Only 9. 1% of leucine transport was sensitive to elimination of the sodium gradient in blood T lymphocytes, which is consistent with most of leucine uptake being mediated by the L-system which is sodium insensitive (Table VII) . Sodium-sensitive leucine uptake was 20% in blood B lymphocytes and 43% in CLL lymphocytes (Table VII) . These data quantify the proportion of leucine transport mediated by sodium-dependent amino acid transport systems, which include the A-and ASC-systems. Methyl-AIB inhibition of leucine transport. Methyl-AIB is a synthetic amino acid that is transported selectively by the Asystem of amino acid transport and can be used to characterize the A-system (12) . We determined which system played the principal role in leucine uptake by examining the methyl-AIB inhibition of leucine uptake; these experiments identified the The data are expressed as the mean±SE of the percent inhibition.
The Pi was measured at a '4C-amino acid concentration of 0.1 mM and the unlabeled (inhibitory) amino acid was present at 5 mM. In the case of blood B lymphocytes, only two studies of BCH inhibition of ['4C]BCH uptake were performed. The data are expressed as the mean±SE in Mimol/l cell water/min.
The v; of amino acid uptake was measured at a concentration of 0.1 mM.
proportion of sodium-sensitive leucine uptake by the A-system. Inhibition of leucine uptake by methyl-AIB in five populations of CLL lymphocytes was only 1±5.1% (Table VIII) . In these studies, methyl-AIB inhibited its own uptake by >87% and BCH uptake by <2%, which was consistent with the specificity of methyl-AIB for the A-system of transport and BCH for the L-system.
Transport ofphenylalanine by CLL, blood B, and T lymphocytes. In order to explore the ability ofCLL cells to transport a second naturally occurring L-system amino acid, phenylalanine uptake was quantified. Total phenylalanine uptake at 0.1 mM was markedly diminished by CLL cells (40) when compared with normal lymphocytes (514 ,mol/l cell water per min). Phenylalanine uptake, unlike that ofleucine, has a large, nonsaturable component, so that our multicomponent analysis could not be applied to determine the kinetic parameters (Km and P..).
In order to isolate the saturable components ofuptake, we studied phenylalanine uptake in a normal and low sodium medium (-10 mM NaCl) and in the presence and absence of a 50-fold excess of BCH. The low sodium medium eliminates the A and ASC components of uptake, and the BCH-sensitive uptake defines the L-system component of phenylalanine transport. The vi for the L-system component of phenylalanine uptake at 0.1 mM phenylalanine was <10% of the uptake by blood B lymphocytes (Table IX) . The vm. for the L-system component of phenylalanine uptake in CLL cells was 80, compared with 800 ,umol/l cell water per min in blood B lymphocytes. (3) lymphocytes (2) lymphocytes ( Transport ofmethyl-AIB by CLL cells and other lymphocyte types. In contrast to the impaired L-system transport in CLL cells, A-system transport, as reflected by the uptake of methyl-AIB, was of greater magnitude in CLL cells than in blood B or T lymphocytes (Table X) . Unseparated tonsillar lymphocytes and tonsillar B cells showed a vi at 0.1 mM for methyl-AIB that was greater than other lymphocytes. The kinetic analysis of methyl-AIB uptake revealed a similar pattern ofA-system transport in the five lymphocyte types studied (Table X) Leucine and phenylalanine transport by the L-system in CLL cells were markedly reduced to <15% ofother B lymphocyte types, which confirmed the very limited L-system transport, as judged by these naturally occurring amino acids. Unlike total phenylalanine uptake, total leucine uptake was considerably greater than predicted by the L-system capacity of CLL cells because ofa "compensatory" shift in uptake to the ASC system. Although there is no specific, naturally occurring or synthetic amino acid to use in inhibition studies to identify the ASC system, the lack of significant methyl-AIB inhibition of leucine uptake, an argument against A-system uptake, and the substantial proportion of sodium-sensitive leucine uptake, strongly implies that the ASC-system is used for leucine uptake in CLL cells.
To our knowledge, this is the first description of a specific deficiency in a major amino acid transport system in a human neoplasm. Genetically defective A-system transport with a marked reduction in the Vms,, for aminoisobutyric acid has been described in a mutant lymphocyte cell line derived from the mouse (17) . The residual A-system transport had a normal affinity for the amino acid, suggesting that the mutant cell line contained a defective regulatory gene, which resulted in the production of a diminished amount of normal protein.
There is precedent for altered protein composition of the lymphocyte plasma membrane in CLL lymphocytes. The cells from 70% of CLL patients show an absence of the enzyme 5'-nucleotidase (3). Further, a decreased actin content, one of the major cytoskeletal proteins, has been described in B cell CLL and may be important in the defective capping of immunoglobulin observed in these cells (18) . Recent studies have shown that CLL cells do not synthesize a 185,000-D cold insoluble globulin that is present in the plasma membrane of normal B lymphocytes (4) . The relationship of the L-system transport protein to the 185,000-D protein or to the decreased glycosylation (2) of other membrane proteins in CLL cells is not known.
The methyl-AIB, i.e. A-system, kinetics of transport in CLL cells and the compensatory increase in leucine uptake by the ASC system indicate that there is not a general defect in amino acid transport, and argue against a metabolic impairment or nonspecific cell damage during cell separation affecting uptake. In addition, A-system transport in CLL cells has been extensively characterized. These studies have shown appropriate increases in A-amino acid transport after amino acid deprivation. This "adaptation" to an A-amino acid-deficient environment was dependent on de novo RNA and protein synthesis, which indicated functionality of the cells and of A-system regulation (19 
